Analyzing food allergy reactions through antibody levels

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to analyze individuals experiencing symptoms related to adverse reactions to foodstuffs. Volunteers over 18 years old, who suspect they have a food allergy or intolerance, will provide a small blood sample for analysis. The study focuses on measuring the levels of food-specific immunoglobulin G4 (IgG4) and immunoglobulin E (IgE) antibodies to better understand their role in food-related symptoms. The findings could help clarify the relationship between these antibodies and food allergies.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adults (\>18 years of age)
* To present symptoms related to adverse reactions to foodstuffs (ARFS)

Exclusion Criteria:

* Antibiotic treatment

Where it's running

• Universidad Politécnica de Madrid
  Madrid, Spain Recruiting

Study contacts

• Principal investigator: Lisset Pantoja-Arévalo, MSc — Universidad Politecnica de Madrid
• Study coordinator: Lisset S Pantoja-Arévalo, MSc
• Email: l.pantoja@upm.es
• Phone: +34910677879

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Symptom Management and Survivorship Coaching for Advanced Cancer Patients and Caregivers

  This study tests a 10-week Symptom Management and Survivorship Handbook plus telephone coaching to help metastatic cancer patients and their caregivers manage symptoms and stay connected.

  Recruiting University of Arizona · Tucson, Arizona · NCT07415564

• Rilzabrutinib versus placebo for adults with IgG4-related disease (52-week treatment)

  This 52-week study will try rilzabrutinib tablets to see if they prevent disease flares and better control symptoms in adults with active IgG4-related disease compared with placebo.

  Recruiting at 91 sites Phase 3 Sanofi · Fontana, California and 94 other locations · NCT07190196

• Registry for Rare Diseases

  This study is creating a detailed registry to collect information on rare diseases like amyloidosis and sarcoidosis to help improve how they are diagnosed and treated.

  Recruiting Hospital Italiano de Buenos Aires · Buenos Aires, Buenos Aires · NCT06573723

• Long-term follow-up on cancer treatment effects and patient quality of life

  This study is trying to see how new cancer treatments affect patients' lives and well-being over time.

  Recruiting Institut Rafael · Levallois-Perret, Institut Rafael · NCT06317714

• A tool to help young cancer patients manage their symptoms

  This study is testing a new computer tool to help young cancer patients better manage their symptoms during treatment.

  Recruiting at 4 sites Virginia Commonwealth University · Kansas City, Missouri and 4 other locations · NCT05958316

• A support system for psychiatric diagnostics and follow-up

  This study is testing new self-assessment tools to help adults share information about their psychiatric symptoms so doctors can make better diagnoses and follow-ups.

  Recruiting at 5 sites Karolinska Institutet · Stockholm and 4 other locations · NCT05827406

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.